Back to Search
GEORGE WOODY, MD
MD
Research Study Specialist
NPI: 1134264708Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial.
PMID 18984887·JAMA·2008
4-observational
HIV risk reduction in the National Institute on Drug Abuse Cocaine Collaborative Treatment Study.
PMID 12792359·J Acquir Immune Defic Syndr·2003
3-trial
An independent assessment of MEDWatch reporting for abuse/dependence and withdrawal from Ultram (tramadol hydrochloride).
PMID 14636971·Drug Alcohol Depend·2003
8-other
Substance use among men who have sex with men: comparison with a national household survey.
PMID 11404525·J Acquir Immune Defic Syndr·2001
4-observational
Efficacy, individual effectiveness, and population effectiveness in substance abuse treatment.
PMID 11123002·Curr Psychiatry Rep·2000
8-other
Predictors of outcome for short-term medically supervised opioid withdrawal during a randomized, multicenter trial of buprenorphine-naloxone and clonidine in the NIDA clinical trials network drug and alcohol dependence.
PMID 18805656·Drug Alcohol Depend·2009
4-observational
Clinical characteristics of treatment-seeking adolescents with opioid versus cannabis/alcohol use disorders.
PMID 18818027·Drug Alcohol Depend·2009
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4110 TIMBER LN
PHILADELPHIA, PA 19129 - Phone
- (215) 823-6066
Quick Facts
- NPI
- 1134264708
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile